Member Info for liquid1

Shares outstanding 620.47m
Free float 286.75m

Only wants to go north.

Asking for 1.49p

Subject to the results of the drilling programme, IAMGOLD has planned a further 5,000 metres follow-up reverse circulation drilling and has also planned 1,000 metres of diamond drilling to test mineralised intervals previously identified. IAMGOLD is currently in Year Three of its earn-in to an initial 51% interest in Senala and, under the terms of the option agreement, must have spent a further US$1 million by the end of February 2021 to keep the option in good standing.

Cash, cash receivables and liquid assets alone could potentially be multiples of current market cap.

https://watermelonshares.wordpress.com/2018/10/10/oriole-resources-orr/

The last test is the biocompatibility test, which tests the reaction to human skin - cytotoxicity, irritation and sensitization. This test has been delayed and is now expected to be completed in the next week.

Assuming that commissioning proceeds as expected, the Company is working towards producing between 0.3m and 0.5m masks before the end of January; before scaling up production to commercial levels in February and March. Discussions are also continuing with Volz Group, which needs to conclude its own certification process, for it to manufacture both a surgical mask and FFP2 masks, although production is not expected to commence much before the end of the first quarter.

Whilst the move to production is a positive step; the success of the operation will be demonstrated through securing sales orders for the Company's products. Whilst interest remains strong, no firm orders have been received as yet with achieving certification an important step for potential customers.

General Meeting

The Board anticipates issuing the notice of general meeting in respect of the placing warrants, as announced on 18 December 2020, in the next week.

18 January 2021

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

Remote Monitored Systems plc ("RMS" or the "Company")

Appointment of Executive director, update on Mask production and General Meeting

Remote Monitored Systems plc ("RMS" or the "Company") announces that further to the announcement on 30 December 2020, the Board has appointed Alex Vergopoulos as an Executive Director of the Company.

Appointment of Alex Vergopoulos

Alex has a wealth of experience in the print and manufacturing industry and has worked closely with one of Pharm 2 Farm Ltd's ("P2F") production partners, who are using their proprietary technology to apply P2F's copper nano particles onto the breathable fabric that makes up the -virion, or viricidal, layer. Alex's initial responsibility will be to oversee the production and sales of the P2F viricidal surgical masks.

Update on mask production

The mask manufacturing machine arrived from Lemu, as expected, and has been installed in a clean room in Nottingham's BioCity. Work begins this week to commission the machine and commence production.

The last element prior to full scale production of the Company's 4-ply mask is the certification of the mask to EN14683 standard (Type IIR). The mask has now passed four of the five required tests, as follows:

Bacterial Filtration Efficiency (BFE): this tests the filtration capacity of the mask. The P2F product achieved a 98.77% result; higher than the 98% required.

Differential Pressure: this tests the breathability of the mask with this test having been previously passed as advised on 15 December 2020. The maximum limit to obtain Type IIR is <60pa/cm(2) . The P2F mask achieved 46.4pa/cm(2) which provides a good balance of breathability and BFE.

Splash resistance: this tests the resistance of the mask to penetration by blood fluid at 16kPa. This test is only required for Type IIR (differentiating it from Type II) as this type of mask can be used in a surgical setting. The key to passing the test is to have a hydrophobic outer layer on the mask. 100% of the masks in the P2F sample passed this test compared to the minimum 90% pass rate requirement.

Microbiological cleanliness: this measures the quantity of microorganisms on the mask, effectively, checking the cleanliness of the manufacturing environment. The P2F masks passed, coming in below the maximum permitted measure of 30 cfu/g (Note: CFU is a microbiological measure for the number of viable cells in a sample).

The last test is the biocompatibility test, which tests the reaction to human skin - cytotoxicity, irritation and sensitization. This test has been delayed and is now expected to be completed in the next week

If successful, P2F will seek both to manufacture disposable face masks in-house and to licence its technology to major face mask producers, in order to supply a global market which generated global revenues of $1.52 billion in 2019 and is estimated to reach $2.45 billion by 2027, registering a compound annual growth rate (CAGR) of 4.4% from 2021 to 2027 (Source: Allied Market Research report May 2020).

https://www.investegate.co.uk/braveheart-inv-group--brh-/rns/final-results/202008040700029977U/

The whole effing world wants this Mask!

Let’s start the production Gareth!

https://palermolive.it/mascherina-killer-uccide-virus/

The 5-layer “killer” mask blocks and kills the virus: it will cost one euro
Written by Pippo Maniscalco
January 16, 2021
The new mask was patented by British chemist Gareth Cave. It will get CE certification next week.

HERE'S HOW IT WORKS

The same scientist who made the "killer" mask explained, as Repubblica reports, the operation of this special device: "When these nanoparticles that make up the central layer are in contact with the virus, they emit ions that penetrate through the surface and they envelop the virus by destroying its genetic material and preventing it from replicating ». These particles, he added, "have a spherical shape and a surface as large as that of the virus and for this reason they are therefore very efficient in killing the unwanted host, but not in reducing the respirability of the mask" . Then there is a last layer which is the one closest to the mouth, which is hypoallergenicand extremely breathable. «Our mask protects not only the wearer but also those around. Because it prevents the virus from reproducing, killing it. Therefore, when we throw it away, we must not be afraid to touch it and we can dispose of it in complete safety because it is not infected ", finally specified its inventor.

The Company expects to provide a further update on expected production levels once the machine has been commissioned and an assessment has been made.

Virus killing activity probably lasts longer that 7 hours, as Dr Gareth Dave stated in his interview, the test was only performed for 7 hours as this facility to test it any longer, does not exist.

Roll on certification next week.

Description
This product is available to pre-order pending certification. No monies will be payable until full certification is achieved.

Prices are for shipping within the UK only.

https://www.pharm2farm.org/product/face-masks-pack-of-10/

Due to large customer interest we have produced the datasheet below. It is a draft and subject to change. The mask products will be sold once certification is complete. Pre-orders can be placed on the shop page.

https://www.pharm2farm.org/face-masks/

Published: 01/15/2021 0

TwitterPinterestWhatsappLinkedIn
It will cost only one euro and the mask that kills the Coronavirus will soon arrive in Italian pharmacies . It was invented by an English professor, expert in nanotechnology and with a chair at Nottingham Trent University. But how does this revolutionary “accessory” work?

How does the mask that kills the Coronavirus work
The mask invented by Professor Gareth Cave consists of five layers . To see it resembles the classic surgical masks but, according to its inventor, it is a real "killer". This is not a hoax: its operation is real and, in a few days, the European Community will approve it for sale . With a guaranteed efficacy for 7 hours , the mask that kills the Coronavirus owes everything to its special composition. Tests conducted in the independent laboratories of Virology Research Services in London certify its filtering capacity (99.8%) and the ability to deactivate Covid-19 and influenza viruses at 90% .

mask that kills the coronavirus - The new British masks discovered against the virus
Ph. Pharm2farm
The role of copper
How does he do it? The "secret" lies in the water-repellent layer , which prevents the inhalation of infected droplets, and above all in the copper coating. This, by releasing ions, kills the virus upon contact. And here is that the mask is no longer a potential means of contagion. Normal surgical masks, in fact, protect the wearer but do not neutralize the virus. Let's assume we come into contact, mask on, with an infected person who is not wearing the mask. If droplets come out of his mouth, and these are deposited on our mask, touching the fabric with your hands (for example while we remove it) we could become infected. Especially if we then bring our hands to our face without having properly washed them. This is precisely the revolution of the mask that kills the Coronavirus: infected droplets are immediately neutralized .

mask that kills coronavirus - DIY and surgical masks
The words of the inventor
“Next week we will get the CE mark and the mask can be marketed throughout Europe. We have recently acquired a production machine, which will start in a few weeks, and in February we will be able to distribute the first batches . We have already had requests from various countries, including Italy ”explained Gareth Cave, interviewed by ITV. Currently the mask has obtained the ISO 18184 certification, which testifies to the antiviral capacity of textile products. And, the credit goes to the antiviral layer soaked in copper nanoparticles, treated with a new technology patented by Pharm2Farm (spin-off of Nottingham Trent University founded by Cave). The spherical particles emit ions upon contact with the virus particles. They destroy its genetic material, stopping its reproduction. However, they do not compromise breathability (the last layer of the mask is hypoallergenic and highly breathable). When fully operational, the production will be 5 million

Even with desperate sellers!

There are several European countries, including Italy, that have requested the first batches of this mask: the manufacture, according to Professor Cave, will be able to provide up to 5 million masks per month

Available throughout Europe after certification.

Nice

The new device was patented by British chemist Gareth Cave. Next week it will obtain the CE certification which will make it possible to sell it (at 1 euro per piece) throughout Europe. Effectiveness guaranteed for 7 consecutive hours.

https://www.repubblica.it/salute/2021/01/12/news/mascherine_nuovo_sistema-282231941/

Derampers can far cough!

Serves them right for selling out today before great news!